CPA
CPXX

Cowen Prime Advisors’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Cowen Prime Advisors’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,000
Closed -$2K – 279
2015
Q2 		$2K Sell
1,000
-18,250
-95% -$41.4K ﹤0.01% 241
2015
Q1 		$48K Hold
19,250
– – 0.02% 184
2014
Q4 		$38K Hold
19,250
– – 0.02% 213
2014
Q3 		$49K Buy
19,250
+7,250
+60% +$19.8K 0.02% 187
2014
Q2 		$36K Sell
12,000
-750
-6% -$2.07K 0.01% 187
2014
Q1 		$40K Buy
+12,750
New +$43.1K 0.02% 186

Other funds holding CPXX

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cowen Prime Advisors's CPXX Position: Q3 2015 in Review

Cowen Prime Advisors sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2015, closing a stake of 1,000 shares — an estimated $2K sold.

Cowen Prime Advisors first reported a position in CPXX in Q1 2014 and held it in 6 quarters. The position peaked at $49K in Q3 2014. 20 funds tracked by Wall St. Rank hold CPXX as of Q3 2015.

  • Cowen Prime Advisors reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2015 after selling out during the quarter.
  • Cowen Prime Advisors sold 1,000 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2015, an estimated $2K.
  • Cowen Prime Advisors first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q1 2014 and held it in 6 quarters.
  • Cowen Prime Advisors's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $49K in Q3 2014.
  • 20 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2015.

Based on Cowen Prime Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.